Results 231 to 240 of about 20,808 (296)

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Rituximab‐refractory pemphigus vulgaris is driven by B‐cell repopulation, plasma‐cell persistence, IgG4 autoantibodies and anti‐drug antibodies. This review evaluates five emerging targeted classes acting at successive steps of disease: next‐generation anti‐CD20 antibodies, DSG3‐CAAR T cells, BTK inhibitors, BAFF/APRIL inhibitors and FcRn antagonists ...
Rhea Ahuja, Dedee Murrell
wiley   +1 more source

Single-Cell Transcriptomics Reveal Human Skin Aging Pathways. [PDF]

open access: yesJ Cosmet Dermatol
Melyukhina K   +6 more
europepmc   +1 more source

Seminal Analysis and Testicular RNA Sequencing of a Ram with Low Fertility. [PDF]

open access: yesAnimals (Basel)
Tejedor MT   +7 more
europepmc   +1 more source

Keratin as a Potential Prognostic Biomarker for Breast Cancer Progression: An Evidence-Synthesizing Narrative Review. [PDF]

open access: yesBreast Cancer (Dove Med Press)
Khairani AF   +4 more
europepmc   +1 more source

Neuroendocrine Carcinoma of the Gallbladder: Clinicopathologic and Immunohistochemical Analysis of 31 Cases. [PDF]

open access: yesAm J Surg Pathol
Reid MD   +14 more
europepmc   +1 more source

Keratinocytes as active regulators of cutaneous and mucosal immunity: a systematic review across inflammatory epithelial disorders. [PDF]

open access: yesFront Immunol
Klimitz FJ   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy